Data News > Top gainers in Disease-fighting Companies - NVAX

Top gainers in Disease-fighting Companies - NVAX

By KlickAnalytics Data Insights  |   June 11, 2024 04:40PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Disease-fighting Companies' theme.

Novavax, Inc. (NVAX)

NVAX is trading UP for the last 1 days, and it at trading at $16.75 with volume of 13,000,705 and a one day change of $0.74 (4.62%). Novavax, Inc. has a 52-week low of 3.53 and a 52-week high of $23.86. The business's 50-day moving average price is $11.00 and its 200 day moving average price is $6.37. The firm has a market cap of $2 million, a P/E ratio of 0.00, and a beta of 1.95.

Top news headlines for NVAX

  • On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains.  Drug manufacturers have been waiting on approval from the agency, whose decision-making was complicated by the fact that the virus keeps mutating.
  • The S&P 500 has hit more than one record high this year, and technology stocks have led the gains. It's a great idea to get in on stocks that have remained in the doldrums but could have a bright future.

  • For more information on NVAX:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.